ArticleJournal of neurology2026
Vestibulocochlear implant (VCI) modulation improves mid and high frequency vestibulo-ocular reflex (VOR).
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe vestibulo-ocular reflex (VOR) stabilizes gaze during head movements by generating compensatory eye movements. In bilateral vestibulopathy (BV), loss of vestibular function leads to loss of VOR and consequently, oscillopsia. Currently, no curative treatment exists. Vestibulocochlear implants (VCI) aim to restore vestibular function by modulating electrical stimulation of the ampullary nerves in response to head motion. Although prior studies have demonstrated partial VOR restoration, a comprehensive evaluation across different stimulation conditions remains limited. This study assessed the effects of multiple stimulation conditions on VOR gain in BV patients implanted with the latest VCI prototype.
methodsNine BV patients were unilaterally implanted with an intralabyrinthine VCI. VOR responses were assessed using rotatory chair testing (mid-frequency domain) and video head impulse testing (vHIT; high-frequency domain). Five stimulation conditions were evaluated: Reference (VI off), Baseline only (constant stimulation), Default (motion modulation around baseline), Lowered baseline (motion modulation around threshold level), and Boosted stimulation (maximized modulation). Subjects were classified into subgroup A (peak eye velocity, PEV, ≥ 30°/s) during lateral ampullary nerve block stimulation and subgroup B (PEV < 30°/s).
resultsSix subjects were classified in subgroup A. In rotatory chair testing, excitatory VOR gain increased significantly under modulated stimulation at all tested frequencies (p < 0.05), with median gains rising from 0.09-0.20 (Reference) to 0.82 (Lowered baseline). No significant inhibitory improvements were observed. In vHIT, subgroup A demonstrated significant excitatory median gain improvements across all canal planes (p < 0.005). Lateral canal gains improved from 0.12 (Reference) to 0.69 (Boosted), and anterior canal median gains up to 0.74. Posterior gains improved but remained < 0.60. Inhibitory gains showed no changes. Subgroup B showed no meaningful gain improvements in any condition. DISCUSSION: Motion-modulated stimulation enhanced excitatory VOR function at mid- and high frequencies in patients who demonstrated higher PEV during block stimulations. However, baseline stimulation alone was ineffective. Lowered baseline and Boosted conditions showed the largest improvements, with gains approaching functional levels in several subjects. However, inhibitory responses remained limited, reflecting physiological and technical constraints. These findings support individualized, frequency-dependent modulation strategies to optimize gaze stabilization and potentially reduce oscillopsia in daily life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.